Blog dedicated to the continuous education in Gynecology and Endocrinology

 

THE EFFECT OF TRANSDERMAL TESTOSTERONE ON MAMMOGRAPHIC DENSITY IN POSTMENOPAUSAL WOMEN NOT RECEIVING SYSTEMIC ESTROGEN THERAPY.

3) J Clin Endocrinol Metab. 2009 Dec;94(12):4907-13.

Davis SR, Hirschberg AL, Wagner LK, Lodhi I, von Schoultz B.

CONTEXT: Greater mammographic density is associated with increased breast cancer risk and reduced diagnostic mammographic sensitivity and may be seen with estrogen/progestin therapy (EPT). The effects of testosterone therapy on mammographic density in postmenopausal women not on EPT are not known. more

Post to Twitter Post to Facebook

THE EFFECT OF TRANSDERMAL TESTOSTERONE ON MAMMOGRAPHIC DENSITY IN POSTMENOPAUSAL WOMEN NOT RECEIVING SYSTEMIC ESTROGEN THERAPY.

1) J Clin Endocrinol Metab. 2009 Dec;94(12):4907-13

Davis SR, Hirschberg AL, Wagner LK, Lodhi I, von Schoultz B.

CONTEXT: Greater mammographic density is associated with increased breast cancer risk and reduced diagnostic mammographic sensitivity and may be seen with estrogen/progestin therapy (EPT). The effects of testosterone therapy on mammographic density in postmenopausal women not on EPT are not known. more

Post to Twitter Post to Facebook

TESTOSTERONE REPLACEMENT THERAPY IN NATURALLY AND SURGICALLY MENOPAUSAL WOMEN.

J Sex Med. 2009 Jan;6(1):8-18;

Panzer C, Guay A.

INTRODUCTION: Testosterone replacement therapy in naturally and surgically menopausal women is a complex and currently highly debated topic. Opposing guidelines for the use of testosterone exist, which create a therapeutic dilemma for clinicians confronted by severely distressed women who experience a decrease in sexual desire after surgical or natural menopause. AIM: In this review, we will address the current knowledge on androgen physiology, conditions associated with a low androgen state, and risks and benefits of androgen therapy. more

Post to Twitter Post to Facebook

STUDY OF ADVERSE OUTCOMES IN WOMEN USING TESTOSTERONE THERAPY.

Maturitas. 2009 Jan 20;62(1):76-80. Epub 2008 Dec 24

van Staa TP, Sprafka JM.

OBJECTIVES: There are concerns that exogenous testosterone therapy may be associated with adverse cardiovascular effects, increases in risk of breast or uterus cancer and alterations in insulin sensitivity. Objective of this study was to explore the safety of testosterone therapy in actual clinical practice. METHODS: Data from the General Practice Research Database and the Health Improvement Network was used, including computerised medical records of UK general practitioners. The study population included women aged 18+ years prescribed testosterone, administered through implants (72.2%), tablets (18.4%) or injections (7.9%). more

Post to Twitter Post to Facebook

The androgen deficiency syndrome in the aging male

powered by WordPress Multibox Plugin v1.3.5

The androgen deficiency syndrome in the aging male
Lunenfeld B.

Post to Twitter Post to Facebook

© International Society of Gynecological Endocrinology - Privacy Policy